Skip to main content
. 2022 Jan;10(2):56. doi: 10.21037/atm-21-6405

Figure 5.

Figure 5

Illustration of molecular pathway of REV-ERBα’s association with cancer progression. Abnormal regulation of REV-ERBα is relevant to cancer malignancy. Downregulation of REV-ERBα can promote cancer cell proliferation and invasion as NF-κB can be upregulated when REV-ERBα was inhibited. NF-κB, nuclear factor-κB.